Geralyn Annett

3.4k total citations
22 papers, 1.7k citations indexed

About

Geralyn Annett is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Geralyn Annett has authored 22 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Geralyn Annett's work include Mesenchymal stem cell research (7 papers), Genetic Neurodegenerative Diseases (5 papers) and Pluripotent Stem Cells Research (4 papers). Geralyn Annett is often cited by papers focused on Mesenchymal stem cell research (7 papers), Genetic Neurodegenerative Diseases (5 papers) and Pluripotent Stem Cells Research (4 papers). Geralyn Annett collaborates with scholars based in United States, Australia and Israel. Geralyn Annett's co-authors include Kenneth I. Weinberg, Jan A. Nolta, Gerhard Bauer, Scott D. Olson, David M. Tishler, Nicholas M. Barbaro, David R. Hinton, Robertson Parkman, Louisa Wirthlin and Nanette C. Joyce and has published in prestigious journals such as Blood, Neurology and Advanced Drug Delivery Reviews.

In The Last Decade

Geralyn Annett

21 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geralyn Annett United States 17 490 442 421 357 342 22 1.7k
Federica Locatelli Italy 31 1.1k 2.3× 1.0k 2.3× 384 0.9× 391 1.1× 149 0.4× 70 2.7k
R. Villani Italy 24 564 1.2× 408 0.9× 192 0.5× 557 1.6× 174 0.5× 92 2.4k
Daniel A. Morgenstern Canada 24 871 1.8× 153 0.3× 363 0.9× 1.0k 2.9× 80 0.2× 89 2.6k
Osamu Tachibana Japan 23 1.2k 2.4× 1.1k 2.4× 571 1.4× 223 0.6× 113 0.3× 105 2.7k
Shuichi Izumoto Japan 25 549 1.1× 579 1.3× 279 0.7× 131 0.4× 151 0.4× 77 1.8k
Adi Vaknin‐Dembinsky Israel 23 627 1.3× 742 1.7× 191 0.5× 209 0.6× 26 0.1× 80 2.3k
Fumio Nakahara Japan 19 547 1.1× 251 0.6× 259 0.6× 165 0.5× 25 0.1× 50 1.7k
Jun‐ichi Kuratsu Japan 26 559 1.1× 822 1.9× 328 0.8× 160 0.4× 56 0.2× 120 2.4k
K. Kuchelmeister Germany 26 502 1.0× 681 1.5× 148 0.4× 187 0.5× 103 0.3× 98 1.8k
Renato Spaziante Italy 28 668 1.4× 614 1.4× 1.0k 2.4× 168 0.5× 50 0.1× 115 3.2k

Countries citing papers authored by Geralyn Annett

Since Specialization
Citations

This map shows the geographic impact of Geralyn Annett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geralyn Annett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geralyn Annett more than expected).

Fields of papers citing papers by Geralyn Annett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geralyn Annett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geralyn Annett. The network helps show where Geralyn Annett may publish in the future.

Co-authorship network of co-authors of Geralyn Annett

This figure shows the co-authorship network connecting the top 25 collaborators of Geralyn Annett. A scholar is included among the top collaborators of Geralyn Annett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geralyn Annett. Geralyn Annett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fierro, Fernando A., Julie R. Beegle, Ping Zhou, et al.. (2018). Mesenchymal stem/stromal cells genetically engineered to produce vascular endothelial growth factor for revascularization in wound healing and ischemic conditions. Transfusion. 59(S1). 893–897. 16 indexed citations
3.
Beegle, Julie R., Stefanos Kalomoiris, Ping Zhou, et al.. (2016). Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia. Molecular Therapy — Methods & Clinical Development. 3. 16053–16053. 55 indexed citations
4.
5.
Deng, Peter, Johnathon D. Anderson, Abigail Yu, et al.. (2016). Engineered BDNF producing cells as a potential treatment for neurologic disease. Expert Opinion on Biological Therapy. 16(8). 1025–1033. 51 indexed citations
6.
Deng, Peter, et al.. (2016). Clinical trial perspective for adult and juvenile Huntington′s disease using genetically-engineered mesenchymal stem cells. Neural Regeneration Research. 11(5). 702–702. 33 indexed citations
7.
Fink, Kyle D., Peter Deng, Joseph S. Anderson, et al.. (2016). Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts. Cell Transplantation. 25(4). 677–686. 50 indexed citations
8.
Fink, Kyle D., Peter Deng, Heather Stewart, et al.. (2015). Developing Stem Cell Therapies for Juvenile and Adult-Onset Huntington's Disease. Regenerative Medicine. 10(5). 623–646. 36 indexed citations
9.
Annett, Geralyn, Gerhard Bauer, & Jan A. Nolta. (2013). Mesenchymal Stem Cells for Trinucleotide Repeat Disorders. Methods in molecular biology. 1010. 79–91. 6 indexed citations
10.
Olson, Scott D., Kari Pollock, Amal Kambal, et al.. (2011). Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington’s Disease. Molecular Neurobiology. 45(1). 87–98. 64 indexed citations
11.
Joyce, Nanette C., Geralyn Annett, Louisa Wirthlin, et al.. (2010). Mesenchymal stem cells for the treatment of neurodegenerative disease. Regenerative Medicine. 5(6). 933–946. 384 indexed citations
12.
Meyerrose, Todd E., Scott D. Olson, Suzanne Pontow, et al.. (2010). Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Advanced Drug Delivery Reviews. 62(12). 1167–1174. 124 indexed citations
13.
Zhou, Ping, Louisa Wirthlin, Jeannine McGee, Geralyn Annett, & Jan A. Nolta. (2009). Contribution of human hematopoietic stem cells to liver repair. Seminars in Immunopathology. 31(3). 411–419. 25 indexed citations
14.
Brooks, Judith, et al.. (2000). T cell depleted haploidentical bone marrow transplantation for the treatment of children with severe combined immunodeficiency.. PubMed. 48(2). 111–8. 23 indexed citations
15.
Appukuttan, Binoy, Elizabeth M. Gillanders, Suh-Hang Hank Juo, et al.. (1999). Localization of a Gene for Duane Retraction Syndrome to Chromosome 2q31. The American Journal of Human Genetics. 65(6). 1639–1646. 77 indexed citations
16.
Bolotin, Ellen, Geralyn Annett, Robertson Parkman, & Kenneth I. Weinberg. (1999). Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplantation. 23(8). 783–788. 175 indexed citations
17.
Tishler, David M., et al.. (1995). MDR1 Gene Expression in Brain of Patients with Medically Intractable Epilepsy. Epilepsia. 36(1). 1–6. 437 indexed citations
18.
Weinberg, Kenneth I., Geralyn Annett, A. Kashyap, et al.. (1995). The effect of thymic function on immunocompetence following bone marrow transplantation.. PubMed. 1(1). 18–23. 125 indexed citations
19.
Annett, Geralyn, et al.. (1994). Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells.. PubMed. 8(11). 1871–8. 18 indexed citations
20.
Weinberg, Kenneth I., et al.. (1992). Correction of antigen-specific T-lymphocyte function by recombinant cytokines in children infected with human immunodeficiency virus type 1. The Journal of Pediatrics. 121(4). 565–568. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Federica Locatelli Breakdown of academic impact, for papers by R. Villani Breakdown of academic impact, for papers by Daniel A. Morgenstern Breakdown of academic impact, for papers by Osamu Tachibana Breakdown of academic impact, for papers by Shuichi Izumoto Breakdown of academic impact, for papers by Adi Vaknin‐Dembinsky Breakdown of academic impact, for papers by Fumio Nakahara Breakdown of academic impact, for papers by Jun‐ichi Kuratsu Breakdown of academic impact, for papers by K. Kuchelmeister Breakdown of academic impact, for papers by Renato Spaziante
Rankless by CCL
2026